The company will market Inivata's InVision liquid biopsy assays to insured and self-pay patients across the region.
In PLOS this week: alternatively spliced form of FBXO38 contributes to chronic obstructive pulmonary disease, evolution of the avian influenza virus H9N2, and more.
By sequencing 10 Bronze, early Iron, and late Iron Age individuals, researchers retraced ancestry patterns at a Philistine port city in present-day Israel.
At the WIN Symposium, a researcher from Sheba Medical Center discussed ongoing efforts to develop a 22-gene signature for predicting brain metastasis in NSCLC.
Variantyx, a 2014 spinout from Tel Aviv University that is based in Framingham, Massachusetts, provides clinical genomic testing for screening and rare disease diagnostics.
In PLOS this week: single protein identification method, Vibrio cholerae sequences from spotted filter paper, and more.
The Israeli online genealogy company recently expanded its ancestry genetic testing offering to include health information.
In PNAS this week: tool to predict pathogenic gene pairs, analysis of bat evolution, and more.
The team sequenced more than 2,200 Saudi families to find the likely source of genetic disease in about 43 percent of cases.
A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.
The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.
Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.